Results 191 to 200 of about 11,390 (207)

Comparative biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral nanoemulsion

Regulatory Toxicology and Pharmacology, 2016
Bapi Gorain, Hira Choudhury, Rakesh Kumar Tekade   +2 more
exaly  

OLMESARTAN

2004
openaire   +1 more source

Administration‐Time‐Dependent Effects of Olmesartan on the Ambulatory Blood Pressure of Essential Hypertension Patients

Chronobiology International, 2009
Ramón C Hermida, Artemio Mojón-Ojea, José R Fernández   +2 more
exaly  

Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability

Colloids and Surfaces B: Biointerfaces, 2017
Chander Parkash Dora, Varun Kushwah, Sanyog Jain   +2 more
exaly  

Olmesartan Medoxomil

Drugs, 2012
exaly  

Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology

Human Pathology, 2016
Benjamin Lebwohl, Carolina Arguelles-Grande, Govind Bhagat   +2 more
exaly  

Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide

Drugs, 2012
exaly  

A Double-Blind, Dose-Response Study of the Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescents with Hypertension

Hypertension, 2010
Asad Bhorat
exaly  

Olmesartan Medoxomil/Amlodipine

Drugs, 2012
exaly  

Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial

European Heart Journal, 2015
Kotaro Nochioka, Hiroaki Shimokawa
exaly